Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02488408
Title Multicenter Open-label Study of BGB324 as a Single Agent and in Combination With Cytarabine in Patients With AML
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors BerGenBio AS
Indications
Therapies
Age Groups: adult
Covered Countries USA | NOR | ITA | DEU

Facility Status City State Zip Country Details
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 United States Details
The University of Texas M.D. Anderson Cancer Center Houston Texas 77030 United States Details
Johann-Wolfgang-Goethe Universität Frankfurt 60596 Germany Details
University Medical Center Hamburg Hamburg 20246 Germany Details
Medizinische Hochschule Hannover Hannover 30625 Germany Details
Universitätsmedizin Mannheim, Universitätsklinikum Mannheim GmbH Mannheim Germany Details
Universitätsklinikum Ulm Ulm 89081 Germany Details
Azienda Ospedaliera S. Cuneo 12100 Italy Details
University of Genoa Genoa 6 16132 Italy Details
U.O. Ematologia - P.O. Vito Fazzi Lecce 73100 Italy Details
Azienda Ospedaliero-Universitaria di Parma Parma 14 43126 Italy Details
Haukelands University Hospital Bergen 5021 Norway Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field